
Early High-Dose Rosuvastatin for Contrast-Induced Nephropathy Prevention in Acute Coronary Syndrome: Results From the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On Contrast-Induced Acute Kidney Injury and Myocardial Damage
Keywords: acute coronary syndrome(s); contrast-induced nephropathy; statins; ACS; acute coronary syndrome(s); CI-AKI; contrast-induced acute kidney injury; eCrCl; estimated creatinine clearance; eGFR; estimated glomerular filtration rate; HMG-CoA; 3-hydroxyl-3-meth